How to obtain severe hypoglycemia without causing brain or cardiac damage

Area of Science:

• Oncology
• Metabolic Medicine
• Biomedical Engineering

Background:

• Cancer is a leading global cause of death with current treatments often insufficient or toxic.
• Emerging evidence suggests non-pharmacological strategies, such as inducing hypoglycemia, may aid cancer treatment.
• Cancer cells preferentially metabolize glucose, exhibiting altered glycolysis and mitochondrial function.

Purpose of the Study:

• To describe a novel method for inducing and maintaining severe hypoglycemia safely.
• To investigate the potential of severe hypoglycemia as an in vivo cancer therapy.
• To explore the use of ExtraCorporeal Membrane Oxygenation (ECMO) for controlled metabolic manipulation.

Main Methods:

• Proposing a technique combining ECMO with selective carotid glucose perfusion.
• Aimed at inducing and sustaining severe hypoglycemia without compromising brain or cardiac function.
• Designing a system to enable in vivo study of cancer cell apoptosis under hypoglycemia.

Main Results:

• Preliminary preclinical and human data suggest hypoglycemia can induce cancer cell apoptosis.
• The proposed ECMO-based method hypothesizes the ability to maintain severe hypoglycemia safely.
• This approach aims to create a controlled environment for studying hypoglycemia's effects on cancer.

Conclusions:

• Severe hypoglycemia presents a potential therapeutic strategy for cancer treatment.
• The proposed ECMO and selective perfusion technique offers a novel approach to safely induce hypoglycemia.
• Further in vivo studies are warranted to validate the efficacy of this hypoglycemia-based cancer therapy.